RegenLab Becomes the First Company Successfully MDSAP Audited In The PRP field.

Posted 16 Oct 2019

Le-Mont-sur Lausanne, October 3, 2019. RegenLab are delighted to announce that they are the first autologous PRP system to be successfully audited under the stringent Medical Device Single Audit Program (MDSAP). MDSAP is a rigorous global harmonised auditing and monitoring procedure for medical devices with three audit phases over a period of three years. It allows the... Read more

Revolutionary t:slim X2™ Insulin Pump from Tandem Diabetes Care® coming to New Zealand patients

Posted 24 Apr 2018

NZMS Diabetes announce a new partnership with Tandem Diabetes Care to introduce the t:slim X2™ Insulin Pump to New Zealand. NZMS Diabetes are delighted to announce they have partnered with Tandem Diabetes Care®, Inc. to introduce the full colour touchscreen t:slim X2™ Insulin Pump to the New Zealand market for the very first time. This partnership is set to benefit New Zealand... Read more

NZMS signs exclusive distribution agreement with Valeritas

NZMS signs exclusive distribution agreement with Valeritas

Posted 18 Apr 2018

NZMS are pleased to announce they have signed an exclusive distribution agreement with Valeritas Holdings, Inc. to market their V-Go® Wearable Insulin Delivery device, for patients with type 2 diabetes, in New Zealand.  “Adding V-Go® to our portfolio is a significant step towards addressing the needs of New Zealand patients with type 2 diabetes who want simple and effective... Read more

Dexcom G5 Mobile wins Healthcare Innovation Award

Posted 27 Jun 2017

New Zealand Medical & Scientific (NZMS) was presented the award for the Dexcom G5 Mobile™ by Jonathan Lucas, partner at James & Wells, at Health Tech Week Gala Dinner. NZMS is the New Zealand distributor for Dexcom Corporation, the United States company that created the device. More than 240,000 New Zealanders have type 1 or 2 diabetes. Dexcom G5™ helps diabetics to... Read more

Results of the PATHWAY study of AspireAssist® have been published.

Posted 8 Dec 2016

Results of the PATHWAY study of AspireAssist®, a 171-subject, multicentre randomized control trial in the US, have been published yesterday in the American Journal of Gastroenterology, which mark a significant milestone for the AspireAssist paving the way for worldwide acceptance and adoption. The published results show that patients lost an average of 37% of their excess weight... Read more

Updated ASTRO guideline

Posted 29 Nov 2016

Updated ASTRO guideline expands pool of suitable candidates for accelerated partial breast irradiation. BioZorb Tissue Marker assists with radiation targeting, including APBI targeting, more information on BioZorb here. Read more

Dexcom G5 Mobile now in New Zealand

Posted 17 Mar 2016

NZMS Diabetes is excited to announce the launch of Dexcom G5 Mobile in New Zealand. Dexcom G5 Mobile is the latest generation CGM featuring mobile connectivity, the ability to remotely share data with up to five followers and superior accuracy giving users freedom from confirmatory fingerprick testing. Read how Dexcom G5 Mobile has helped the Hall family in the NZ Herald article here.... Read more

New Medicina ENFit ISO Enteral feeding system range

New Medicina ENFit ISO Enteral feeding system range

Posted 8 Nov 2015

NZMS and Medicina are pleased to announce, that in line with the joint effort worldwide, the new ISO Standard 80369-3 Reducing the risk of medical device tubing misconnections for enteral feeding will be available for our New Zealand Customers. The new Medicina ENFit ISO Enteral feeding system range includes a low dose syringe for the smallest of patients and has been developed to deliver... Read more